Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pol Specenier. (2018) Nivolumab in squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 18:5, pages 409-420.
Read now
Read now
Pol Specenier & Jan Vermorken. (2016) Afatinib in squamous cell carcinoma of the head and neck. Expert Opinion on Pharmacotherapy 17:9, pages 1295-1301.
Read now
Read now
Edgar Selzer & Gabriela Kornek. (2013) Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments. Expert Review of Clinical Pharmacology 6:6, pages 663-676.
Read now
Read now
Articles from other publishers (12)
Maria L. Espinosa, Chelsea Abad, Yaira Kurtzman & Farah R. Abdulla. (2021) Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers. Frontiers in Oncology 11.
Crossref
Crossref
S. B. Alieva, R. I. Azizyan, A. M. Mudunov, I. A. Zaderenko, N. A. Daykhes, V. Z. Dobrokhotova, E. N. Novozhilova, S. S. Reshulskiy, T. N. Borisova & V. V. Vinogradov. (2021) Principles of radiotherapy for laryngeal cancer. Head and Neck Tumors (HNT) 11:1, pages 24-33.
Crossref
Crossref
Shigeki Suzuki, Hang Yuan, Shizu Hirata-Tsuchiya, Kazuma Yoshida, Akiko Sato, Eiji Nemoto, Hideki Shiba & Satoru Yamada. (2021) DMP-1 promoter-associated antisense strand non-coding RNA, panRNA-DMP-1, physically associates with EGFR to repress EGF-induced squamous cell carcinoma migration. Molecular and Cellular Biochemistry 476:4, pages 1673-1690.
Crossref
Crossref
Mohammed M. Al Qaraghuli. (2020) Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies. Frontiers in Oncology 10.
Crossref
Crossref
Paolo Pisani, Mario Airoldi, Anastasia Allais, Paolo Aluffi Valletti, Mariapina Battista, Marco Benazzo, Roberto Briatore, Salvatore Cacciola, Salvatore Cocuzza, Andrea Colombo, Bice Conti, Alberto Costanzo, Laura della Vecchia, Nerina Denaro, Cesare Fantozzi, Danilo Galizia, Massimiliano Garzaro, Ida Genta, Gabriela Alejandra Iasi, Marco Krengli, Vincenzo Landolfo, Giovanni Vittorio Lanza, Mauro Magnano, Maurizio Mancuso, Roberto Maroldi, Laura Masini, Marco Carlo Merlano, Marco Piemonte, Silvia Pisani, Adriele Prina-Mello, Luca Prioglio, Maria Gabriella Rugiu, Felice Scasso, Agostino Serra, Guido Valente, Micol Zannetti & Angelo Zigliani. (2020) Metastatic disease in head & neck oncologyLa malattia metastatica in oncologia testa-collo. Acta Otorhinolaryngologica Italica 40:SUPPL. 1, pages S1-S86.
Crossref
Crossref
Bianka Gurbi, Diána Brauswetter, Attila Varga, Pál Gyulavári, Kinga Pénzes, József Murányi, Veronika Zámbó, Ede Birtalan, Tibor Krenács, David Laurence Becker, Miklós Csala, István Vályi-Nagy, István Peták & Kornél Dános. (2019) The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies. Cancers 11:12, pages 1848.
Crossref
Crossref
Manpreet Sambi & Myron R. Szewczuk. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies
1
33
.
Xin Liu, Jessica K. Lukowski, Colin Flinders, Seungil Kim, Rebecca A. Georgiadis, Shannon M. Mumenthaler & Amanda B. Hummon. (2018) MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon-Cancer Cell Cultures. Analytical Chemistry 90:24, pages 14156-14164.
Crossref
Crossref
Renato José Silva-Oliveira, Matias Melendez, Olga Martinho, Maicon F. Zanon, Luciano de Souza Viana, André Lopes Carvalho & Rui Manuel Reis. (2017)
AKT can modulate the
in vitro
response of HNSCC cells to irreversible EGFR inhibitors
. Oncotarget 8:32, pages 53288-53301.
Crossref
Crossref
Laura Lattanzio, Federica Tonissi, Martino Monteverde, Daniela Vivenza, Elvio Russi, Gérard Milano, Marco Merlano & Cristiana Lo Nigro. (2015) Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines. Investigational New Drugs 33:2, pages 310-320.
Crossref
Crossref
Christos Petrides, Neofytou Kyriakos, Ioannou Andreas, Parpounas Konstantinos, Georgiou Chrysanthos, Petrou Athanasios & Emmanouil Pikoulis. (2015) Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland. Case Reports in Surgery 2015, pages 1-3.
Crossref
Crossref
Floor C. J. van de Watering, Mark Rijpkema, Lars Perk, Ulrich Brinkmann, Wim J. G. Oyen & Otto C. Boerman. (2014) Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients. BioMed Research International 2014, pages 1-13.
Crossref
Crossref